Company intelligence / Profile preview
Handok
- Ownership
- Public · 002390
- Employees
- ~550
- Development stage
- Other
Overview
Handok has a robust commercial portfolio including both prescription and OTC drugs. It has several approved drugs for diabetes (e.g., Amaryl MEX), oncology (Pemigatinib for cholangiocarcinoma), allergy treatment (Fexofenadine Hydrochloride), hematology/oncology biologics such as Tafasitamab-Cxix for lymphoma. The company also develops medical devices and diagnostics. Recent clinical highlights include positive Phase 2/3 results from its collaborator Compass Therapeutics on Tovecimig for cancer immunotherapy and ongoing late-stage trials with affiliates like Rezolute in rare metabolic diseases.
- Therapeutic areas
- OncologyEndocrinologyImmunologyHematology
- Modalities
- Small moleculesbispecific antibodiesFc fragmentssynthetic peptides
- Industry
- Biotech
Drug pipeline
4 assets3 more assets in the full pipeline.
Partnerships
Financials
- Market cap
- $78.9M
- Total revenue
- $392.4M
- Enterprise value
- $336.2M
Beyond the preview
Go deeper on Handok.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Handok.